Navigation Links
Genentech/Roche's Lucentis and Eli Lilly's Ruboxistaurin Will Drive the Diabetic Retinopathy and Nephropathy Drug Markets
Date:9/24/2007

Longer Term Growth of Diabetic Neuropathy Market Will Be Driven by Launches of Disease-Modifying Therapies, According to a New Report from Decision

Resources

WALTHAM, Mass., Sept. 24 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that by 2016 Genentech/Roche's Lucentis and Eli Lilly's ruboxistaurin will drive the markets for the treatment of diabetic retinopathy and diabetic nephropathy.

The new Pharmacor report entitled Diabetic Complications: Retinopathy, Neuropathy, and Nephropathy finds that, over the next decade, treatment of diabetic complications will expand considerably beyond tight control of blood pressure and glucose levels. Lucentis and ruboxistaurin will come the closest to achieving blockbuster status as treatments for diabetic complications in the world's major pharmaceutical markets -- the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Additionally, although promising drug classes with potential disease-modifying activity that include PKC inhibitors and aldose reductase inhibitors have suffered a decade of setbacks and disappointing efficacy data, the report finds that longer-term market growth will be driven by several of these novel therapies.

Therapies for the painful symptoms of diabetic neuropathy will continue to dominate sales, and few patients suffering non-painful diabetic neuropathy will receive treatment until the launches of disease-modifying therapies near the midpoint of the 2006-2016 forecast period.

"The diabetic neuropathy market will experience growth during the second half of our study period because of increasing use of Pfizer's antiepileptic drug, Lyrica, and Eli Lilly's antidepressant Cymbalta, which are both approved specifically for the treatment of diabetic neuropathic pain," said Donny Wong, Ph.D., analyst at Decision Resources. "Longer term
'/>"/>

SOURCE Decision Resources
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. FDA Approval For Lucentis
2. Ruboxistaurin (RBX) may prevent vision loss in diabetic patients
3. Ruboxistaurin As A Novel Treatment For Diabetic Nephropathy
4. Sleepy drivers increase road death toll
5. Traffic Violations Result in Safer Drivers
6. Dyslexia may slow a drivers reaction time as much as moderate drinking!!
7. Study suggests symptom driven therapy for adults with asthma
8. Peppermint or cinnamon smell can make drivers more alert
9. Mechanical forces drive early heart development
10. Measles Vaccination Drive Intensified In Quake-Hit Pakistan
11. More Funds Are Required For Immunisation Drive
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Feed additives have now become an ... chain. Most of the feed additives are used in ... and powders. There are variety of feed additives available ... upon the type of animal and feed. Nutritional feed ... essential nutrition to the animal in order to gain ...
(Date:5/21/2013)... Patients of Dr. Michael Shenk and Dr. Judd Shenk ... gum disease and would like permanent tooth replacements now have ... laser gum surgery. Gum disease must be treated prior ... of all tooth replacement options. , The Laser Assisted ... by the Food and Drug Administration (FDA) that greatly improves ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 ContinuCare Home ... Texas Department of Aging and Disability Services. After completing ... employee interviews, ContinuCare Home Health was found to ... review is part of the Department of Aging and ... aging and disability services, supports and opportunities that ...
(Date:5/21/2013)... 2013, Paris, France: One-year results from SOURCE XT ... (TAVI) registries to-date reported today at EuroPCR 2013 ... high rates of device success for all access approaches, ... Post-Approval Study followed up 2688 consecutively enrolled patients (mean ... heart valve at 93 centres in 17 countries between ...
(Date:5/21/2013)... 2013 The In View series ... and cable channels across the country, announces it has ... channel. The producers of the series proudly bring audiences ... industry, the manufacturing industry, health-related companies, medical facilities and ... medical practitioners in all parts of the United States, ...
Breaking Medicine News(10 mins):Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 2Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 3Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 4Health News:Shenk Dental Care Stimulates Bone Growth for Gum Disease Patients Seeking Dental Implants with Laser Gum Surgery in Atlanta, GA 2Health News:ContinuCare Home Health, Inc. Receives Perfect Report from the Texas Department of Aging and Disability Services 2Health News:In View hosted by Larry King Announces New Videos on its YouTube Channel 2
... out that certain ordinary drugs like//anti-psychotic and gastro-intestinal drugs ... study, which was published in the European Heart Journal, ... activity controlling heartbeats that can increase the risk of ... can prolong the duration of electrical activity that controls ...
... Harvard Medical School have reported that birth weight and// adult ... of coronary heart disease. ,Over 66,000 female nurses were ... ,The results of the research show that higher the ... chance of having coronary heart disease. For each kg increase ...
... Hospital, Boston, US, have reported that a diet// with low ... cardiovascular disease than the conventional low fat diet. ,A ... Glycemic Index (GI) ranks foods on their effect on the ... Some food items raise the blood glucose level more than ...
... US had approved the first test that// uses DNA in blood ... Fibrosis Kit and it can analyze DNA samples from the blood ... in children and in adults. The test can not only predict ... identify the people who are not having the disease but are ...
... A drink a day may reduce the risk of kidney ... males, who had moderate consumption of alcohol weekly (about a ... reduced glomerular filtration rates with men who drank less than ... the drinking pattern and renal function of these men through ...
... biomarker for prostate cancer cells do// that it will become ... was hidden inside the cells, can now be moved to ... blood. This will make it possible for the medical professionals ... immunotherapy, for better and more effective way to kill the ...
Cached Medicine News:
(Date:5/21/2013)... TEANECK, N.J. , May 21, 2013 /PRNewswire-iReach/ ... 17-19 in NJ has attracted the greatest number ... reports its President, Mark Alexay ... "But suddenly everyone plans to attend this year.  The show,s still ... of different companies.  This is a big surprise ...
(Date:5/21/2013)... 2013  IsoRay, Inc. (AMEX: ISR ), ... into an exclusive international distribution agreement with IASIS Medical ... Greece . IsoRay is a medical ... radioisotope applications for brain cancer, lung cancer, head and ... IASIS Medical is ideally suited to support ...
(Date:5/21/2013)... 2013  The North Shore-LIJ Health System is expanding ... compliance at North Shore University Hospital in ... rooms at Forest Hills (NY) ... The new pilot program strengthens patient safety by providing ... the first time in the US that remote video ...
Breaking Medicine Technology:Emerging Pharma at ChemOutsourcing 2013 in Record Numbers for Upcoming September Show 2IsoRay Announces A New International Distributor For Greece 2IsoRay Announces A New International Distributor For Greece 3North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 2North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 3North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 4
... 2011 Reportlinker.com announces that a new market ... Global Ophthalmic Instrumentation Industry ... This report analyzes the worldwide markets for Ophthalmic ... by the following segments: Diagnostic Devices (Perimeters, Refractors, ...
... FREMONT, Calif., Feb. 2, 2011 WaferGen Biosystems, Inc. ... state-of-the-art genomic analysis systems, today announced that it will present an ... Investor Conference in New York City at the Waldorf Astoria Hotel, ... will be webcast live and archived for 90 days and may ...
Cached Medicine Technology:Global Ophthalmic Instrumentation Industry 2Global Ophthalmic Instrumentation Industry 3Global Ophthalmic Instrumentation Industry 4Global Ophthalmic Instrumentation Industry 5Global Ophthalmic Instrumentation Industry 6Global Ophthalmic Instrumentation Industry 7Global Ophthalmic Instrumentation Industry 8Global Ophthalmic Instrumentation Industry 9Global Ophthalmic Instrumentation Industry 10Global Ophthalmic Instrumentation Industry 11Global Ophthalmic Instrumentation Industry 12Global Ophthalmic Instrumentation Industry 13Global Ophthalmic Instrumentation Industry 14Global Ophthalmic Instrumentation Industry 15Global Ophthalmic Instrumentation Industry 16Global Ophthalmic Instrumentation Industry 17Global Ophthalmic Instrumentation Industry 18Global Ophthalmic Instrumentation Industry 19Global Ophthalmic Instrumentation Industry 20Global Ophthalmic Instrumentation Industry 21Global Ophthalmic Instrumentation Industry 22Global Ophthalmic Instrumentation Industry 23Global Ophthalmic Instrumentation Industry 24Global Ophthalmic Instrumentation Industry 25WaferGen to Present at 13th Annual BIO CEO and Investor Conference 2
... very easy to use Ambulatory Urodynamic recorder ... with practising urologists as an invaluable aid ... dysfunctions. The system offers the possibility to ... a natural bladder filling, extented over a ...
... high technology state-of-the-art system offering complete urodynamic ... for every user. The flexible system configurations ... as well as research purposes. The Solar ... you to obtain the functionality that is ...
... offers the ultimate research level wireless Urodynamics ... clinician and researcher today. Offering superb design ... meet your desired footprint requirements. Choose from ... live data both in the room and ...
... TRITON™ offers ultimate flexibility by allowing you ... printer and display. Wall-mount anywhere in the ... choosing a laptop, touch screen tablet, industrial ... technology, this multi-function patient tower provides more ...
Medicine Products: